JU

Jayasankar Unnikrishnan Cheenikuzhi

Active Director Director DIN 05129304
DIN 05129304 First appointment Feb 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2012
Shareholding value •••• Premium profile

About Jayasankar Unnikrishnan Cheenikuzhi

Data last updated:

Jayasankar Unnikrishnan Cheenikuzhi is a Director at Sphygmose Pharmaceutical Private Limited (since 2012). The company operates in Pharma. Sphygmose Pharmaceutical Private Limited reported revenue of ₹18.3 Lakh (FY 2025).

DIN 05129304
Primary Designation Director
Industry Pharma
First Appointment 02 Feb 2012
Oldest Company Age 14 yrs
Largest company Sphygmose Pharmaceutical Private Limited · ₹18.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Feb 20122012₹18.3 Lakh (FY 2025)Active

Board colleagues of Jayasankar Unnikrishnan Cheenikuzhi

NameDINCompanyDesignation
Praveen Praveen05129310Sphygmose Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sphygmose Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Jayasankar Unnikrishnan Cheenikuzhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayasankar Unnikrishnan Cheenikuzhi

Jayasankar Unnikrishnan Cheenikuzhi currently holds 1 directorship: Sphygmose Pharmaceutical Private Limited (Director, since 02 Feb 2012, revenue ₹18.3 Lakh (FY 2025)).

Jayasankar Unnikrishnan Cheenikuzhi was first appointed on 02 Feb 2012 as Director at Sphygmose Pharmaceutical Private Limited.

The current boards of Jayasankar Unnikrishnan Cheenikuzhi's companies include Praveen Praveen (Sphygmose Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available